Director John F. Crowley resigns from Entrada board; Chapman and Parmar fill committee vacancies

Entrada Therapeutics, Inc.

John F. Crowley resigned from Board, Audit Committee, and as Chair of Compensation Committee, effective December 5, 2023.
Resignation not due to any disagreement with the Company's operations, policies, or practices.
Board appointed Gina Chapman to Audit Committee and Kush M. Parmar, M.D., Ph.D. as member and Chair of Compensation Committee.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John F. Crowley

member of the Board of Directors

TRDA · Entrada Therapeutics, Inc.

Effective: 2023-12-05
Filed: December 6, 2023, 6:59 PM ET

On December 5, 2023, John F. Crowley, a member of the Board of Directors (the “Board”) of Entrada Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board, including the Audit Committee of the Board (the “Audit Committee”), on which he serves as a member, and the Compensation Committee of the Board (the “Compensation Committee”), on which he serves as the Chair, effective December 5, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John F. Crowley resigned as member of the Board of Directors at Entrada Therapeutics, Inc..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On December 5, 2023, John F. Crowley, a member of the Board of Directors (the “Board”) of Entrada Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board, including the Audit Committee of the Board (the “Audit Committee”), on which he serves as a member, and the Compensation Committee of the Board (the “Compensation Committee”), on which he serves as the Chair, effective December 5, 2023.

View on SEC.gov

Entrada Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-123805

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.